Australian prescribers' perspectives on ART initiation in the era of "treatment as prevention"

Limin Mao, John de Wit, Philippe Adam, Jeffrey Post, Levinia Crooks, Michael R Kidd, Sean Slavin, Susan Kippax, Edwina Jane Wright

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Abstract

This study explores Australian prescribers attitudes towards Treatment as Prevention (TasP) and their practices around initiating combination antiretroviral treatment (cART) for HIV. A brief online survey was conducted nationally amongst antiretroviral treatment (ART) prescribers in Australia. The sample broadly represented ART prescribers in Australia (N = 108), with 40.7 general practitioners (GPs), 25.9 sexual health clinic-based physicians and 21.3 hospital-based infectious diseases physicians. About 60 of respondents had been treating HIV-positive patients for more than 10 years. Respondents estimated that about 70-80 of all their HIV-positive patients were receiving ART. Over half of the prescribers agreed very strongly that their primary concern in recommending cART initiation was clinical benefit to individual patients rather than any population benefit. A majority of the prescribers (68.5 ) strongly endorsed cART initiation before CD4+ T-cell count drops below 350 cells/mm3, and a further 22.2 strongly endorsed cART initiation before CD4+ T-cell count drops below 500 cells/mm3. Regarding the optimal timing of cART initiation, this study shows that prescribers in Australia in 2012 focus primarily on the benefits for their individual patients. Prescribers may need more convincing evidence of individual health benefits or increased knowledge about the population health benefits for a TasP approach to be effective in Australia. ? 2013 ? 2013 Taylor Francis.
Original languageEnglish
Pages (from-to)1375 - 1379
Number of pages5
JournalAids Care: Psychological and Socio-Medical Aspects of AIDS/HIV
Volume25
Issue number11
DOIs
Publication statusPublished - 2013

Cite this

Mao, Limin ; de Wit, John ; Adam, Philippe ; Post, Jeffrey ; Crooks, Levinia ; Kidd, Michael R ; Slavin, Sean ; Kippax, Susan ; Wright, Edwina Jane. / Australian prescribers' perspectives on ART initiation in the era of "treatment as prevention". In: Aids Care: Psychological and Socio-Medical Aspects of AIDS/HIV. 2013 ; Vol. 25, No. 11. pp. 1375 - 1379.
@article{08563096f93744cf9ba4a6f1c38af629,
title = "Australian prescribers' perspectives on ART initiation in the era of {"}treatment as prevention{"}",
abstract = "This study explores Australian prescribers attitudes towards Treatment as Prevention (TasP) and their practices around initiating combination antiretroviral treatment (cART) for HIV. A brief online survey was conducted nationally amongst antiretroviral treatment (ART) prescribers in Australia. The sample broadly represented ART prescribers in Australia (N = 108), with 40.7 general practitioners (GPs), 25.9 sexual health clinic-based physicians and 21.3 hospital-based infectious diseases physicians. About 60 of respondents had been treating HIV-positive patients for more than 10 years. Respondents estimated that about 70-80 of all their HIV-positive patients were receiving ART. Over half of the prescribers agreed very strongly that their primary concern in recommending cART initiation was clinical benefit to individual patients rather than any population benefit. A majority of the prescribers (68.5 ) strongly endorsed cART initiation before CD4+ T-cell count drops below 350 cells/mm3, and a further 22.2 strongly endorsed cART initiation before CD4+ T-cell count drops below 500 cells/mm3. Regarding the optimal timing of cART initiation, this study shows that prescribers in Australia in 2012 focus primarily on the benefits for their individual patients. Prescribers may need more convincing evidence of individual health benefits or increased knowledge about the population health benefits for a TasP approach to be effective in Australia. ? 2013 ? 2013 Taylor Francis.",
author = "Limin Mao and {de Wit}, John and Philippe Adam and Jeffrey Post and Levinia Crooks and Kidd, {Michael R} and Sean Slavin and Susan Kippax and Wright, {Edwina Jane}",
year = "2013",
doi = "10.1080/09540121.2013.766304",
language = "English",
volume = "25",
pages = "1375 -- 1379",
journal = "Aids Care: Psychological and Socio-Medical Aspects of AIDS/HIV",
issn = "0954-0121",
publisher = "Routledge",
number = "11",

}

Australian prescribers' perspectives on ART initiation in the era of "treatment as prevention". / Mao, Limin; de Wit, John; Adam, Philippe; Post, Jeffrey; Crooks, Levinia; Kidd, Michael R; Slavin, Sean; Kippax, Susan; Wright, Edwina Jane.

In: Aids Care: Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 25, No. 11, 2013, p. 1375 - 1379.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Australian prescribers' perspectives on ART initiation in the era of "treatment as prevention"

AU - Mao, Limin

AU - de Wit, John

AU - Adam, Philippe

AU - Post, Jeffrey

AU - Crooks, Levinia

AU - Kidd, Michael R

AU - Slavin, Sean

AU - Kippax, Susan

AU - Wright, Edwina Jane

PY - 2013

Y1 - 2013

N2 - This study explores Australian prescribers attitudes towards Treatment as Prevention (TasP) and their practices around initiating combination antiretroviral treatment (cART) for HIV. A brief online survey was conducted nationally amongst antiretroviral treatment (ART) prescribers in Australia. The sample broadly represented ART prescribers in Australia (N = 108), with 40.7 general practitioners (GPs), 25.9 sexual health clinic-based physicians and 21.3 hospital-based infectious diseases physicians. About 60 of respondents had been treating HIV-positive patients for more than 10 years. Respondents estimated that about 70-80 of all their HIV-positive patients were receiving ART. Over half of the prescribers agreed very strongly that their primary concern in recommending cART initiation was clinical benefit to individual patients rather than any population benefit. A majority of the prescribers (68.5 ) strongly endorsed cART initiation before CD4+ T-cell count drops below 350 cells/mm3, and a further 22.2 strongly endorsed cART initiation before CD4+ T-cell count drops below 500 cells/mm3. Regarding the optimal timing of cART initiation, this study shows that prescribers in Australia in 2012 focus primarily on the benefits for their individual patients. Prescribers may need more convincing evidence of individual health benefits or increased knowledge about the population health benefits for a TasP approach to be effective in Australia. ? 2013 ? 2013 Taylor Francis.

AB - This study explores Australian prescribers attitudes towards Treatment as Prevention (TasP) and their practices around initiating combination antiretroviral treatment (cART) for HIV. A brief online survey was conducted nationally amongst antiretroviral treatment (ART) prescribers in Australia. The sample broadly represented ART prescribers in Australia (N = 108), with 40.7 general practitioners (GPs), 25.9 sexual health clinic-based physicians and 21.3 hospital-based infectious diseases physicians. About 60 of respondents had been treating HIV-positive patients for more than 10 years. Respondents estimated that about 70-80 of all their HIV-positive patients were receiving ART. Over half of the prescribers agreed very strongly that their primary concern in recommending cART initiation was clinical benefit to individual patients rather than any population benefit. A majority of the prescribers (68.5 ) strongly endorsed cART initiation before CD4+ T-cell count drops below 350 cells/mm3, and a further 22.2 strongly endorsed cART initiation before CD4+ T-cell count drops below 500 cells/mm3. Regarding the optimal timing of cART initiation, this study shows that prescribers in Australia in 2012 focus primarily on the benefits for their individual patients. Prescribers may need more convincing evidence of individual health benefits or increased knowledge about the population health benefits for a TasP approach to be effective in Australia. ? 2013 ? 2013 Taylor Francis.

UR - http://www.ncbi.nlm.nih.gov/pubmed/23406458

U2 - 10.1080/09540121.2013.766304

DO - 10.1080/09540121.2013.766304

M3 - Article

VL - 25

SP - 1375

EP - 1379

JO - Aids Care: Psychological and Socio-Medical Aspects of AIDS/HIV

JF - Aids Care: Psychological and Socio-Medical Aspects of AIDS/HIV

SN - 0954-0121

IS - 11

ER -